$BIVI 3 SEC Filings

Filed On	Filing
28 Oct 2025	Form 3: Farag Kameel D., Director No securities owned
27 Oct 2025	Form 3: Chappell Amy Suzon, Director No securities owned
16 Aug 2022	Form 3: Peizer Terren S, Director No securities owned
10 Nov 2021	Form 3: Palumbo Joseph M, Chief Medical Officer No securities owned
08 Oct 2021	Form 3: Reading Christopher, EVP Neuroscience R&D No securities owned
28 Sep 2021	Form 3: Berman Richard J, Director No securities owned
28 Sep 2021	Form 3: Ahlem Clarence N., EVP of Product Development No securities owned
28 Sep 2021	Form 3: Hariri Robert J, Director No securities owned
20 Mar 2019	Form 3: Kim Joanne Wendy, Chief Financial officer
14 Mar 2019	Form 3: Markham Penelope, Chief Science Officer
13 Mar 2019	Form 3: Kumar Hari, Director Holds 136,364 shares of Common Stock
13 Mar 2019	Form 3: Yeramian Patrick D, Chief Medical Officer
04 Sep 2018	Form 3: Wieland R Richard, interim CFO
15 Aug 2018	Form 3: Lang James Paul, Director Holds 250,000 shares of common stock
14 Aug 2018	Form 3: Sooch Mina, Director Holds 263,636 shares of common stock
14 Aug 2018	Form 3: Do Cuong V, Director Holds 2,671,354 shares of common stock
09 Aug 2018	Form 3: Anderson Julie G, Director Holds 100,000 shares of common stock
09 Aug 2018	Form 3: Adams Jonathan M, Director Holds 6,168,067 shares of common stock
01 Aug 2018	Form 3: Sherman Michael Edward, Director Holds 68,181 shares of common stock

Comments